Would a phase I study of an IND drug with a limited phase II MTD expansion require results to be reported? 1.64K viewsOctober 10, 2022Clinical Research 0 Sam Smith11.38K November 23, 2020 0 Comments Spread the loveSpread the love 1 Answer ActiveVotedNewestOldest 0 Blogolu28.38K Posted November 23, 2020 0 Comments Spread the loveYes. If the study is considered Phase I/II, the “II” portion takes precedence and must be registered if it meets the other requirements of being an applicable clinical trial. Spread the love You are viewing 1 out of 1 answers, click here to view all answers. Login
